Abstract
Background To achieve the World Health Organization targets for cervical cancer elimination, low- and middle income countries must develop innovative strategies to provide human papillomavirus (HPV) -based screening at a population level. Mobile health may help fill gaps in electronic specimen tracking and patient education. We sought to develop a mobile health application (“mSaada”) to support HPV-based screening in partnership with community health volunteers and program planners in western Kenya.
Methods A team of student programmers developed a prototype to meet previously identified gaps in screening patient education, protocol support, data capture and specimen tracking. The protoype was iteratively developed through three waves of in-person working sessions with quantitative and qualitative feedback, with planned improvements in mSaada functionality after each wave of in-person data collection. Results: Twelve Community Health Volunteers (CHVs) and clinicians took part in the in-person sessions. Participants found mSaada useful and easy to use. Key feedback was used to alter the appearance of the mainframes, add translation in additional local languages and change potentially embarrassing figures. Participants also suggested workflow design and technology needs necessary for sustainability.
Conclusion Using a process of iterative feedback with key stakeholders and rapid response from developers, we have developed a mobile application ready for pilot testing in HPV-based screening programs led by CHVs.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This study was funded by an NIH grant (R01CA188428) and Duke Cancer Institute Pilot Grant.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
We obtained ethical approval from Duke University Campus Institutional Review Board (2019-0650) and the KEMRI Scientific and Ethical Review Unit (SERU 3894). All participants provided written informed consent prior to initiation of study activities.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Data is available upon request
